LONDON, February 6, 2024 /PRNewswire/ – Curaleaf Worldwide (the “Firm”), a part of Curaleaf Holdings (TSX: CURA) and Europe the most important vertically built-in hashish firm, is happy to announce its acquisition of Can4Med, a distinguished pharmaceutical wholesaler specializing in cannabinoid medicines in Poland. This strategic transfer marks a big milestone for each corporations and highlights Curaleaf's dedication to enhancing affected person entry to high-quality medical hashish merchandise throughout Europe. Poland boasts one in every of Europe the bigger affected person inhabitants looking for medical hashish; by becoming a member of forces with Can4Med, Curaleaf Worldwide features a robust foothold on this dynamic market, permitting it to serve sufferers extra successfully and increase its product providing.
“This acquisition represents a big step ahead for Curaleaf Worldwide. of Poland The medical hashish market is increasing quickly, and our partnership with Can4Med permits us to raised serve sufferers whereas driving general progress. Europe“, he mentioned Matt DarinCEO of Curaleaf.
“We’re excited that Can4med, a pioneering power in of Poland the hashish market, has joined forces with Curaleaf, the world chief in hashish. This acquisition marks a big milestone in our journey, making certain an unparalleled provide chain that positions us to fulfill and exceed the calls for of your entire Polish market. The partnership with Curaleaf not solely reinforces our dedication to high quality and affordability, but in addition signifies a brand new period of progress and prospects for each companies and our prospects,” he mentioned. Maximilian Weinbergfounding father of Can4med.
As Poland stands on the forefront of the European hashish market, its substantial inhabitants of 38 million is poised to catalyze vital progress and innovation within the sector. The Polish Pharmaceutical Chamber estimates that the potential variety of medical hashish customers might attain 300,000, whereas the variety of authorized hashish customers (each medical and CBD) is anticipated to succeed in 1.3 million by 2026.
In 2023 alone, the nation witnessed a outstanding progress within the adoption of medical hashish, with greater than 3,000 kg distributed in Poland, reflecting a rising acceptance and recognition of its therapeutic advantages. This growth is supported by an enormous community of medical professionals approved to prescribe hashish. Regardless of the advanced registration course of that producers and sufferers need to navigate, Curaleaf Worldwide, by means of its subsidiary 4 20 Pharma GmbH, has emerged as a number one power, securing its place as one of many solely licensed producers within the Polish market. This unique standing highlights Curaleaf's strategic foresight and dedication to fulfill the rigorous requirements of compliance and high quality required to function on this rising market, setting a benchmark for excellence and reliability within the European hashish business.
About Curaleaf Worldwide: Curaleaf Worldwide, a subsidiary of Curaleaf Holdings, is Europe the most important vertically built-in hashish firm. With a robust historical past of product innovation and regulatory compliance, Curaleaf Worldwide has established itself as a trusted provider of cannabis-based medicines in key European markets.
About Can4Med: Can4Med is an skilled pharmaceutical wholesaler specializing within the buy, registration and distribution of medical hashish and merchandise containing THC and different cannabinoids in Poland. The corporate's deal with importing and distributing cannabinoid medicines has positioned it as a vital hyperlink within the provide chain, making certain that sufferers have entry to secure and efficient remedies. Can4Med has a pharmaceutical wholesaler's license that permits the advertising and marketing and distribution of narcotic medicine for medical functions and permits the wholesale sale of medicinal merchandise and pharmaceutical uncooked supplies for pharmacy prescriptions. Backed by an skilled and skilled administration workforce and workers, Can4Med is properly positioned to register and distribute hashish merchandise all through Poland.
https://www.prnewswire.com/news-releases/curaleaf-international-acquires-can4med-expanding-presence-in-polands-growing-medical-cannabis-market-302054778.html
